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Summary
BACKGROUND: Chronically ill and ageing populations
demand increasing human resources who can provide on-
going and frequent follow-up care. We performed a sys-
tematic review to assess the effect of physician-nurse sub-
stitution on process care outcomes.
METHODS: We searched OVID Medline, Embase,
CINAHL and The Cochrane Library for all available dates
up to August 2012 and updated in February 2014. We se-
lected and critically appraised published randomised con-
trolled trials (RCT) and followed the PRISMA guidelines
for the reporting of systematic reviews.
RESULTS: A total of 14 RCTs comprising 10,743 parti-
cipants met the inclusion criteria. Studies were generally
small and suffered from attrition of ≥20% and selection bi-
ases. There were 53 process measurements investigated in
the 14 RCTs, many of which were unique to specific con-
ditions. Accounts of nurses’ roles, responsibilities, tasks,
qualifications and training content/components were not
described in sufficient detail. Most study estimates showed
no significant differences between nurse-led care and
physician-led care while less than a half (~40%) favoured
nurse-led care.
CONCLUSIONS: Despite the methodological limitations
and the varying nurses’ roles and competencies across
studies, specially trained nurses can provide care that is at
least as equivalent to care provided by physicians for the
management of chronic diseases, in terms of process of
care. Future, larger studies with better quality methods are
needed and should report and assess whether the differen-
ces in effects vary due to diversity in roles, qualifications,
training competencies and characteristics of clinicians de-
livering substitution of care.
Key words: systematic review; physician-nurse
substitution; primary healthcare; chronic disease; delivery
of healthcare; process indicators
Introduction
The need for healthcare services is becoming more hetero-
geneous as the burden of chronic diseases and population
ageing spreads rapidly. Chronically ill and ageing popu-
lations are expected to rise as the main users of health-
care services until at least mid-twenty-first century. Con-
sequently, these populations are bound to have more ex-
tended care needs (including psychosocial and behavioural
support) and an increased demand for human resources. A
WHO report however, showed the global number of health
care providers, namely physicians, nurses and midwives,
remains lower than required per 1,000 population [1–3]. By
2011, 57 countries were still facing a critical shortage of
these health workers including regions in Africa, Eastern
Mediterranean, South-East Asia, Western Pacific, Amer-
icas and Europe [4]. Factors greatly contributing to this
shortage include the low flow of primary care physicians
(less graduates selecting and remaining in the primary care
sector), changes in the working culture (e.g. newer gener-
ations of physicians working fewer hours than prior gen-
erations) and trends in retirement [5]. These changes have
provided plenty of opportunities to create innovative staff-
mix models [6].
It has long been suggested that nurses should perform
greater roles and be granted full practice [7]. Indeed, nurses
already provide an increasingly important contribution in
primary care and although decreasing in number, they are
still one of the largest groups of qualified healthcare pro-
fessionals and they are also less expensive than physicians.
Therefore their role for substituting physicians has gained
increasing interest from policymakers hoping to address
workforce shortages and maldistribution of workload,
while reducing costs, especially in the care for the chronic-
ally ill [2, 8]. However at this time, it has been difficult to
demonstrate how best to integrate nurses in a substitution
model of care. Especially with the variability in definitions
of nurses' roles and the diversity of competencies among
roles with the same name or differing roles and skills
among healthcare systems, this integration may seem
doubtful. Nevertheless, nurses’ education keeps evolving
in order to adjust to new demands in healthcare and nurses
continue to support physicians in many areas in many
countries. Substitution may take place in a wide range of
care settings and/or clinical areas. It involves the transfer
of tasks which are traditionally from the domain of physi-
cians, to nurses who then take autonomous or delegated re-
sponsibilities to deliver care.
In 2002 and 2005, two systematic reviews explored the
substitution of physicians by nurses in primary care and
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 1 of 21
concluded with no appreciable differences between nurse-
led care and physician-led care in terms of health outcomes
(patient satisfaction, quality of life, other morbidity), use
of resources and healthcare costs [9, 10]. However, authors
found insufficient data on process outcomes other than
length of consultations, amount of prescriptions and invest-
igations, consultations and referrals. The identified eviden-
ce also had methodological limitations and lacked clear re-
porting of nurses’ roles (qualifications and training) and on
the use of guidelines. We performed a timely update of pre-
vious reviews [9, 10] with a focus on the process of care
outcomes, other than those examined in the mentioned re-
views, and on the type and degree of nurses’ competencies.
Methods
This study was part of a large systematic review and meta-
analysis project designed to assess the evidence of
physician-nurse substitution in primary care. The method-
ological procedures of this systematic review are similar
to those employed in the reviews of this project reported
elsewhere [11]. We developed a protocol prior to the com-
mencement of the review and followed the PRISMA
guidelines [12] for the reporting of systematic reviews and
meta-analyses (additional file, table S1).
Study inclusion and exclusion criteria
We searched for peer reviewed randomised or quasi-ran-
domised (e.g., controlled before-and-after studies, interrup-
ted time series) controlled trials (RCTs) published in Eng-
lish. Studies were eligible if they fulfilled the following
criteria: examined populations of all ages and all conditions
including mental health and addiction restricted to primary
care; assigned patients to nurse-led care (all nurse roles)
or physician-led care (family physicians, paediatricians and
geriatricians) based on a substitution model; and if care in-
terventions had taken place in general practices, commu-
nity or ambulatory care settings regardless of the recruit-
ment sources. We further limited the inclusion of studies
to the report of process of care outcomes, which meant
measures that reflected whether clinicians performed cer-
tain steps in diagnostic and treatments that are considered
to be state of the art based on guidelines or good clinical
practice (e.g. specific examinations/diagnostic tests, com-
pliance with monitoring schemes). Following a framework
published by a Cochrane review [10], we excluded studies
in which nurses supplemented (i.e. complemented or exten-
ded care) the work of physicians or in which the effect of
nurse-led care could not be distinguished from collaborat-
ive teams. We excluded measures of quality of life, satis-
faction, mortality, hospital admissions, progression of dis-
ease and other clinical parameters.
Study identification and search strategy
We comprehensively searched OVID Medline, Embase,
CINAHL and The Cochrane Library which includes the
Cochrane Effective Practice and Organization of Care
Group (EPOC). The original search was supported by an
expert librarian. All searches were first performed for all
available dates until August 2012. The searches were not
restricted by age, date or country and included terms for
‘primary care’, ‘skill mix’, ‘doctors’, ‘nurse’, ‘substitution’
(additional file, table S2). We identified additional studies
by manual searching of the reference lists of included stud-
ies and relevant reviews. Both electronic and manual
searches were updated in February 2014.
Assessment of study quality
In view of the continuing debate about scoring the quality
of trials, discussed by Juni et al. (1999) [13], a composite
score was not performed. We assessed the risk of bias of
individual trials following established criteria [14, 15] and
provide a description of the studies’ adequacy regarding
each item and an overall judgment of the quality of eviden-
ce. We considered bias due to attrition of at least 20% to be
of significant concern and adequate intention-to-treat (ITT)
when authors analysed participants based on their original
group allocation [16].
Selection and assessment of studies
Two authors independently screened titles and abstracts,
assessed the full-text of eligible publications and the risk of
bias of included studies. Differences were resolved in dis-
cussion or by consensus with another author.
Data extraction
Two authors independently conducted data abstraction us-
ing a-priori designed and standardised data collection
forms. We extracted information on bibliographic details,
settings and characteristics of populations, interventions
(nurses’ training competency and role, type of care, wheth-
er nurses were granted full clinical autonomy and whether
interventions were delivered following specific protocols
or guidelines, length of follow-up) and outcomes. Using
the description of interventions and qualifications reported
by study authors we grouped nurses’ training and roles in-
to: nurse practitioner (NP) or nurse practitioner (NP+) who
took or already had -for the purposes of the study- high-
er degree courses or had a specialisation; registered nurse
(RN) or licensed nurse (LN). We also extracted quantitat-
ive and semi-quantitative data in dichotomous and/or con-
tinuous format. Data from trials reported across more than
one publication were extracted as one study. If trials re-
ported more than one comparison group of interest (e.g.
family physicians and paediatricians), data were combined
and compared as one to nurse-led care. We did not contact
study authors to obtain additional information or data. Dif-
ferences were resolved through consensus.
Statistical analyses
There was mostly one study per outcome thus we did not
perform meta-analyses nor did we pre-specify subgroup
analyses by clinical or methodological (risk of bias) char-
acteristics. Where data were sufficiently reported, for each
study outcome we calculated the unadjusted relative risks
(RR) or the standard mean differences (SMD) and 95%
confidence intervals (CI) of the absolute endpoints, using
Review Manager (Version 5.1) [17]. We considered p
<0.05 as statisticaly significant. The calculated effect sizes
were tabulated with information on nurses’ roles and stud-
ies were arranged, within outcome categories, in increasing
length of follow-up. The results were synthesised qualitat-
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ively. When scales pointed in opposite directions, we sub-
tracted the mean from the maximum possible value of the
scale or multiplied the mean of a set of studies by ‒1.
We followed reported techniques to estimate standard de-
viations (SD) when these were missing [15]: using the in-
formation from the reported statistical analyses (e.g. from
median and interquartile ranges), and if SDs of the final
measurements were unavailable, we carried forward the
baseline SDs assuming the intervention did not alter the
variability of the outcome. Medians were treated differ-
ently from means and are reported distinguishably.
Results
Study identification
A total of 4,589 original records were identified by the
electronic and manual searches. Of these, 44 publications
were relevant, but 24 were excluded for the reasons
provided in table S3 (additional file). Finally, 14 RCTs re-
ported in 20 publications, met the inclusion criteria and
comprised a total of 10,743 randomised participants
[18–37]. Figure 1 shows the process of study selection.
Study and population characteristics
Table 1 and table S4 (additional file) show the study and
population characteristics of included studies. All RCTs in-
dividually assigned participants to intervention and control
groups and were conducted in the UK (n = 6), the Nether-
lands (n = 5), the USA (n = 2), and Russia (n = 1). Median
follow-up was 12 (range 0.5 to 48) months with at least 12
months in 7 trials and less than 12 months in the other 7.
The number of participants ranged from 60 to 1,859 with
less than 200 (range 60 to 175) in six trials and more than
200 (range 230 to 1,859) in the other eight. Age was repor-
ted in twelve trials. Mean age ranged from 11.2 (SD 2.9) to
69.5 (SD 10.6) years in ten trials and age ranged from 0 to
83 in other two. In 13 RCTs that reported on gender, 49%
of the population were male (range: 27 to 64%).
Figure 1
Flow diagram – study selection process.
Settings and interventions
Table 2 and table S4 (additional file) report the charac-
teristics of settings and interventions. Nurses worked as
physician substitutes in physicians’ practices, nurse clinics,
hospital outpatient clinics, reference clinics, and medical
health centres. A total of 10 trials reported the number of
participating nurses and/or physicians. In ten, the median
number of nurses was 7.5 (range: 2 to 28) while in sev-
en, the median number of physicians was 14 (range: 5 to
50). The location of practices (rural or urban) and social
settings were scarcely reported. Nurses delivered care for
a wide range of possible (diverse/undifferentiated/minor
acute/common) or specific conditions (e.g. hypertension,
heart failure, diabetes, HIV, etc.). Care provided ranged
from single contact care, on-going care, first contact only
care, first contact and on-going care, and first contact for
urgent care. Only four trials [25, 27, 30, 36] reported the
nurses’ years of experience (range: 0.17 to 12) and only
one [25] reported that physicians had 16 years of exper-
ience. Nine trials employed NPs (NPs or NP+), and the
rest employed LNs and/or RNs and/or NPs. Nurses were
either enrolled as staff, took courses or already had pro-
fessional qualifications by the time of participating in the
study. Unfortunately, the educational preparation of nurses
was reported insufficiently. Only four studies specifically
stated that nurses had obtained an academic degree either
a Masters in Advance Nursing [25], a Diploma in General
Practice and implied an NP degree [30], a special degree in
patient education [18], or had done a degree level course
[36]. The terminology used by study authors to refer to par-
ticipating nurses in the studies did not provide a straight-
forward definition of the various nurses’ educational de-
grees from the countries, at least for the UK, Netherlands
and Russia. For example, a NP in the US requires a gradu-
ate degree whereas the UK did not seem to have a minim-
um educational requirement until this was recommended in
2012 for advanced NPs [38]. A “hypertension nurse” may
then refer to a NP or a practice nurse both of whom are
specialists in hypertension but each of whom might hold
different educational degrees, for example basic education
at diploma or degree level plus/or a bachelor’s or a mas-
ter’s degree. The content of training or experience was of-
ten not described in detail. The lack of this information im-
peded a detailed assessment of the level of education and
competencies, and the identification of common compon-
ents across trials. All studies however, seem to assume that
nurses fulfilled the appropriate clinical competency to de-
liver the study interventions. Responsibilities and tasks also
varied across trials and were often incomplete. Nurses had
full clinical autonomy in only two trials: one in patients
with undifferentiated conditions [26] and one in diabetic
patients [28]. In the remaining trials, nurses independently
performed several tasks, but they still needed minor sup-
port from physicians, for example to report findings, sign
prescriptions, referrals and hospitalisations, or to discuss
patients’ records. Ten trials reported nurses’ interventions
followed specific guidelines or protocols.
Risk of bias in the methods of the included studies
The overall quality of studies varied substantially when as-
sessed against current reporting standards [14] (table 3). In-
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clusion and exclusion criteria were reported in 71% of the
trials and funding sources in 64% of the trials. The success
of the intervention was measured by defining a primary
outcome in 50%. Among all trials, random sequence gener-
ation was adequate in 57%, allocation concealment in 50%
and both criteria were adequate in 43%. No trial blinded
both patients and providers. Patients were blinded in one
trial, and outcome assessors were blinded in 36%. Patient
or clinician crossover between groups was reported in two
trials. Sample size calculation (80 to 90% power) was per-
formed in 79% of the trials but only five maintained the re-
quired sample to achieve power. At baseline, patient groups
were comparable for all tested factors in 71%. Attrition rate
was ≥20% in 43%. Missing data (range 5 to 42%) was dealt
with intention to treat (ITT) techniques in 29%.
Effectiveness of interventions
We identified 53 measurements of process of care reported
in the 14 RCTs. Of these, 34 were reported in ten trials
in which nurses cared for patients with specific conditions.
The other 19 process of care measures were reported in
four trials in which nurses cared for patients with more gen-
eral conditions. Table 4 and table 5 show the individual tri-
al estimates calculated from reported data.
Adherence to practical guidelines
Adherence of clinicians to practical guidelines was non-
significant between groups in one trial [25].
Blood pressure management according to guidelines
Blood pressure management according to guidelines
showed significantly more patients in the nurse group,
compared to physicians, met a composite target (SBP and
Table 1: Summary of study and population characteristics of studies included in review.
Study Participants Nurse group Physician group
First author,
publication (y)
Location Design, period* diagnosis Nurses
(n)
Patients
(n)
Mean
age
(SD),
years
Male, % Physicians
(n)
Patients
(n)
Mean age
(SD),
years
Male, %
Houweling et al.
2011
NL 5 RCT, period NR DM2 2 116 67.1 (11) 53 5 114 69.5
(10.6)
42
Kuethe et al. 2011 NL 4 RCT, 2006–2008 Asthma NR 36 11.2 (2.9) 64 NR 71 11.2
(2.5)†
10.1
(2.6)‡
58
Voogdt-Pruis et al.
2010
NL 3 RCT, 2006–2007 CVD, hypertension,
hypercholesterolaemia
6 808 64 (9.0) 58 25 818 64 (9.0) 62
Andryukhin et al.
2010
RU 1 RCT, 2006 -2009 Heart failure with
preserved ejection
fraction
10 50 66.5 (3.2) 27 8 50 68 (4.3) 34
Dierick-Van Daele
et al. 2009
NL 2 RCT, 2006 Common complaints 12 817 42.8
(16.5)
38 50/17§ 684 46.1
(16.6)
40
Chan et al. 2009 UK 6 RCT, 2002–2004 GORD, moderate
gastritis
NR 89 50.2
(13.9)
49 NR 86 48.4
(12.8)
49
Hesselink et al.
2004
NL 1 RCT, 1998–2002 Asthma and COPD 2 139 49.9
(14.2)
35 14 137 44.7
(13.6)
28
Denver et al. 2003 UK 5 RCT, 2000–2001 DM2, hypertension,
under blood pressure
lowering treatment
NR 60 58.1
(13.8)
57 NR 60 62.4 (9.1) 70
Jarman et al.
2002
UK 4 RCT, 1996–1999 Parkinson's disease 9 1041 NR 57 NR 818 NR 56
Kinnersley et al.
2000
UK 3 RCT, period NR Diverse 12 1465¶ Range: 0
to >75
39 10 1465¶ Range:
0–>75
42
Shum et al. 2000 UK 2 RCT, 1998–1999 Acute minor illnesses 5 900 Median
(IQR):
26
(9–41.8)
40 19 915 Median
(IQR):
29.1
(9.7–44.9)
40
Campbell et al.
1998
UK 1 RCT, 1995–1996 CHD secondary
prevention
28 673 66.1 (8.2) 58 NR 670 66.3 (8.2) 58
Flynn et al. 1974 US 2 RCT, 1971 Undifferentiated 4 40 NR NR NR 20 NR NR
Lewis et al. 1967 US 1 RCT, period NR Hypertension, CVD,
obesity, arthritis,
somatisation
NR 33 Range:
16–78
12 NR 33 Range:
16–83
12
Studies are listed by year (y) of publication, in decreasing order.
NL = The Netherlands; UK = United Kingdom; US = United States; RU = Russia; NR = not reported; DM(2) = diabetes mellitus (type 2); GORD = gastro-oesophageal reflux
disease; CVD = cardiovascular disease; COPD = chronic obstructive pulmonary disease; CHD = coronary heart disease; SD = standard deviation.
* Start and end year when studies were conducted
† General physicians
‡ Paediatricians
§ Reference practices for comparison on economic/cost data
¶ Number of randomised patients per group not reported
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Table 2: Summary characteristics of settings and interventions of studies included in review.
Study Setting/
Facilities, n
Disease Intervention
First author,
publication (y)
Location diagnosis Delivered
by
Training/
competency
FCA GDL 1stC UV OC C, n FUP, m
Houweling et al.
2011
NL 5 Practice, 1 DM2 NP Practice nurse
with one week
training in
diabetes mellitus;
nurse had no
special training in
the treatment of
diabetes prior to
starting trial
Yes Yes No No Yes >1 14
Kuethe et al.
2011
NL 4 HO, 1; Practice,
18
Asthma NP+ Asthma nurse No Yes No No Yes >1 24
Voogdt-Pruis et
al. 2010
NL 3 Healthcare
centre, 6
CVD, Hypertension,
Hypercholesterolaemia
NP+ Advance practice
nurse already
employed to
manage patients
with asthma,
chronic
obstructive
pulmonary
disease, or
diabetes
NR Yes No No Yes >1 12
Andryukhin et
al. 2010
RU 1 Medical center
practice, 1.
Heart Failure with
preserved ejection
fraction
NP/LN Nurses with
special degree in
patient education
obtained in a joint
course
No Yes No No Yes >1 6
Dierick-Van
Daele et al.
2009
NL 2 Practice, 15;
Reference, 5
Common complaints NP+ Nurse practitioner
with Masters in
Advance Nursing
trained in
common
complaints
No Yes Yes No No 1 0.5, AC
Chan et al.
2009
UK 6 Nurse clinic, 1 GORD, moderate
gastritis
NP+ Gastrointestinal
nurse practitioner
No Yes No No Yes >1 6
Hesselink et al.
2004
NL 1 Practice, 12 Asthma and COPD LN GP assistant with
pre- and during-
trial training to
deal with the
differences
between asthma
and COPD
No Yes* No No Yes >1 12, 24
Denver et al.
2003
UK 5 Nurse HB
Hypertension
clinic, n = NR
DM2, hypertension,
under blood pressure
lowering treatment
NP+ Hypertension
nurse
No Yes No No Yes >1 6
Jarman et al.
2002
UK 4 Practice, 438 Parkinson's disease LN Community nurse
with a course in
Parkinson
disease
No NR No No Yes >1 24
Kinnersley et al.
2000
UK 3 Practice, 10 Diverse NP Nurse
practitioners with
diploma on care
for same day
consultations for
primary care
No NR Yes Yes No 1 AC, 0.5
Shum et al.
2000
UK 2 Practice, 5 Acute minor illnesses NP Practice nurse
with no specific
experience in
minor illnesses
but with a course
in management of
minor illnesses
and were piloted
before starting
study
No NR Yes Yes No ≥1 0.5 –1
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Campbell et al.
1998
UK 1 Practice, 19 CHD secondary
prevention
NP District and
practice nurses
trained in clinic
protocols/GDLs
for behavioural
techniques
change
No Yes No No Yes >1 12, 48
Flynn et al.
1974
US 2 HO clinic, 1;
Private, 3
Undifferentiated RN Nurse clinicians
with training in
service delivery
including health
status, quantity
and efficiency of
care
Yes NR Yes No Yes >1 6–12
Lewis et al.
1967
US 1 UH clinic, 1;
Nurse clinic, 1
Hypertension, CVD,
obesity, arthritis,
somatization
LN Nurses who
provided primary
source care for at
least one year
before the study
No Yes No No Yes >1 12
Studies are listed by year (y) of publication, in decreasing order.
NL, = The Netherlands; UK = United Kingdom; US = United States; RU = Russia; NR = not reported; DM(2) = diabetes mellitus (type 2); GORD = gastro-oesophageal
reflux disease; CVD = cardiovascular disease; COPD = chronic obstructive pulmonary disease; NP = nurse practitioner; NP+ = nurse practitioner with higher degree/
course; RN = registered nurse; LN = licensed nurse; FCA = full clinical autonomy; GDLs = whether interventions guidelines or protocol based; 1st C = 1st contact; UV =
urgent visits; OC = on-going care; C(n) = number of consultations; FUP = follow-up episodes in months; NR = not reported; AC = after consultation.
DPB, mm Hg: RR 1.1, 95% CI 1.06 to 1.13, p <0.00001)
[20] and systolic blood pressure target (SBP, mm Hg RR
3.14, 95% CI 1.38 to 7.19, p = 0.007) [24]. However, the
effect did not sustain at 48 [20] or 14 months [28] and was
non-significant for DPB only [24].
Lipids
Significantly more patients in nurse-led care, compared to
physicians, had appropriate secondary prevention of heart
disease through the adequate management of lipids at 12
months following specific guidelines in one trial (RR 1.91,
95% CI 1.59 to 2.29, p <0.00001) [20]. However, these dif-
ferences were non-significant at 14 or 48 months.
HbA1c
One trial showed no significant differences between nurse-
led care and physician-led care in the number of patients
who met the target values of glycated haemoglobin
(HbA1c) according to guidelines for the management of
diabetes mellitus type 2 at 14 months (HbA1c <7.0 or
HbA1c ≤8.5) [28].
BMI and waist circumference
In one trial, compared to the physicians group, there were
significantly more patients in the nurse group who had
a decrease or regression in body mass index (BMI) at 6
months (RR 1.51, 95% CI 1.05 to 2.17, p = 0.03) [18] but
the mean differences between groups at 12 or 14 months
were non-significant in other two trials [28, 37]. One of
Table 3: Summary of risk of bias in the included studies.
OutcomeStudy, first author Country Inclusion &
exclusion
criteria
1ry 2ry
Sequence
generation
Allocation
concealment
Blinding Sample
size
Attrition, % Funding
Houweling et al. 2011 NL 5 ? ? ? I A NP ? <20 G
Kuethe et al. 2011 NL 4 ? ? A A NP ? <20 NR
Voogdt-Pruis et al. 2010 NL 3 ? ? A U I‡ ? <20 P/Ind.
Andryukhin et al. 2010 RU 1 ? U I † ? ≥20 None
Dierick-Van Daele et al. 2009 NL 2 ? A A NP NP ≥20 G
Chan et al. 2009 UK 6 ? A A † ? <20§ NR
Hesselink et al. 2004 NL 1 * ? ? U U † ? ≥20 NR
Denver et al. 2003 UK 5 * ? ? I I NP ? <20§ NR
Jarman et al. 2002 UK 4 ? ? ? A A NP ? <20 P/Ind.
Kinnersley et al. 2000 UK 3 ? ? ? A A NP ? ≥20 G
Shum et al. 2000 UK 2 ? A A NP ? ≥20 G
Campbell et al. 1998 UK 1 ? A I † ? ≥20§ G
Flynn et al. 1974 US 2 * U U NP NR <20 NR
Lewis et al. 1967 US 1 * U U † NR U§ G
Studies are listed by year (y) of publication, in decreasing order.
Blinding: whether patients, care providers and outcome assessors were blinded. Attrition of ≥20% is of significant concern. A tick indicates the specific criteria fulfilled. I =
inadequate; A = adequate; U = unclear; NP = not performed; NR = not reported; NL = The Netherlands; UK = United Kingdom; US = United States; RU = Russia; funding:
government (G), industry (Ind.) or private (P) grant.
* Only inclusion criteria was reported
† Trials with blinding of outcome assessors for all or some outcomes
‡ Only patients were blinded
§ Performed intention to treat (ITT) strategies to deal with missing data
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these also showed significantly more patients in the nurse
group who had a decrease or regression in waist circumfer-
ence at 6 months (RR 2.36, 95% CI 1.34 to 4.16, p = 0.003)
[18].
Asthma
Individual point estimates of one trial showed, compared to
physician-led care, significantly more patients with a cor-
rect inhalation technique at 12 months in the nurse-led care
group (RR 1.33, 95% CI 1.01 to 1.74, p = 0.04) [27], but
the effect was non-significant at 24 months. In another tri-
al, the differences between groups in the number of patients
with well-controlled asthma were non-significant at 12 or
24 months [31].
Feet at risk
Compared to patients in physician-led care, there were sig-
nificantly less patients with feet-not-at-risk in the nurse-led
care group (of the patients who underwent measures to pre-
vent the development of diabetic foot symptoms) (RR 0.59,
95% CI 0.42 to 0.82, p = 0.002) [28].
Visuomotor coordination
There was a significant improvement in best hand score in
patients with nurse-led care, compared to patients in the
physicians group in patients with Parkinson’s disease in
one trial (MD –4.31, 95% CI –4.52 to –4.11, p <0.00001)
[29].
Appropriate secondary prevention
Individual point estimates from one trial [20] showed sig-
nificantly more patients with nurse-led care, compared to
physician-led care, had appropriate secondary prevention
of heart disease through the adequate management of aspir-
in intake (taken or contraindicated) (RR 1.22, 95% CI 1.14
to 1.31, p <0.00001) or low-fat diet (RR 1.16, 95% CI 1.03
to 1.31, p = 0.02) or moderate physical activity (RR 1.35,
95% CI 1.16 to 1.58, p = 0.0001) at 12 months. However,
the effect did not sustain at 48 months except for moderate
physical activity (RR 1.23, 95% CI 1.02 to 1.49, p = 0.03).
Conversely, there were no significant differences between
groups in the number of patients who had appropriate sec-
ondary prevention of heart disease through non-smoking
at 12 or 48 months [20] or smoking cessation for asthma/
COPD at 24 months in one trial [27].
Adherence to treatment, correct medication and diet
Adherence to treatment (in patients under anti-inflammat-
ory agents) was non-significant between groups neither at
12 nor at 24 months in one trial [27]. Another trial showed
a marginal significance that favoured the nurse-led care
group in the number of patients who adhered to milk as part
of their nutritional diet (RR 0.62, 95% CI 0.38 to 1, p =
0.05) [26] but no significant differences between groups in
the number of patients who adhered to a special diet, bread
taking, or with correct medication, at 6–12 months.
Patient information and knowledge
Seven trials reported on various types of provision of in-
formation, advice from clinicians or patient knowledge.
There were generally one or two trials per outcome type.
Nurses provided significantly more information than phys-
icians on the causes of health problems or illness [22, 30]
in two of the three trials with these data. Nurses also gave
significantly more advice about relief of symptoms, dura-
tion of illness, how to reduce recurrences and what to do if
problems persisted in one [30] of two trials [25, 30]; as well
as more advice on self-medication and self-management
[36], special exercises [26], and provided leaflets about pa-
tients illness [22]. Patients’ knowledge about the complic-
ations of disease was non-significant between groups [26].
In another trial, although data was collected, results were
not reported [32].
There was no evidence of worsening outcomes with nurse-
led care compared to physician-led care.
Discussion
Substitution of physicians by nurses has increased the pos-
sibility of achieving the quality outcomes required to sat-
isfy the demands of an aging population and the shortages
of physicians in many countries. We found however that
the number of studies in this area is only increasing slowly
despite previous reports [9, 10]. The studies were generally
small and none fulfilled all quality criteria. More than 40%
of the studies suffered from selection (lack/unclear alloc-
ation concealment and random generation) and attrition
(≥20%) biases, and very probable publication bias since
our review was limited to the published literature. Only
a few studies maintained the sample required to achieve
power and the length of follow up varied widely. It may not
be surprising that most of the evaluated trials were conduc-
ted in Europe, mainly the UK, and the Netherlands. In the
USA and Canada medical care has evolved to a shared role
since NPs and physicians’ assistants were introduced or re-
invigorated, both in the mid-1960s [39]. However, the USA
is still in great need of more nurses to level out the shortage
of primary care physicians [40, 41]. In the UK on the other
hand, the introduction of nurses in advanced roles did not
happen until early 1970s and the role of NPs were not con-
solidated until 1990 [42].
The studies generally assessed a large variety of process
of care outcomes, sometimes with many unique measure-
ments per study but only 38.3% (13/34) of those taken
in patients with specific conditions and 42.1% (8/19) re-
lated to general conditions, significantly favoured nurse-
led care compared to physicians. The remaining studies
showed non-significant differences.
The competencies to treat the elderly and the chronically ill
may differ among different types of nurses or physicians.
Research has reported a reduction in mortality, failure-
to-rescue rates, ulcers and length of stay after increasing
the proportion of nurses who possess a bachelor’s degree
[43–47]. However, unless stated by study authors, the eval-
uated literature does not offer sufficiently reported details
on nurses’ educational level. The literature reflects an over-
use of terminology for nurses’ job titles. In addition,
nurses’ qualifications did not seem consistent among these,
although nurses had received training to deliver the in-
terventions. Nor was it possible to make clear judgments
about nurses’ educational level by using a country’s defini-
tion of the terminology that authors used to refer to nurses.
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Table 4: Individual trial estimates from binary data.
Reference details Interventions,
delivered by
Outcome reported FUP, m Nurse
group,
n/N
Physician
group,
n/N
RR (95%
CI)
p-value
Blood pressure appropriately managed according to guidelines
Denver et al. 2003 NP+ SBP target achieved: 140/80 mm Hg for patients without renal
complications; 120/70 mm Hg for patients with renal complications
6 20/53 6/50 3.14
(1.38 to
7.19)
0.007
Denver et al. 2003 NP+ DBP target achieved:140/80 mm Hg for patients without renal
complications; 120/70 mm Hg for patients with renal complications
6 30/60 22/60 1.36 (0.9
to 2.07)
0.150
Campbell et al. 1998 NP SBP and DBP target achieved 160/90 mm Hg 12 572/593 510/580 1.1 (1.06
to 1.13)
<0.00001
Houweling et al. 2011 NP SBP and DBP target achieved <140/90 mm Hg 14 26/102 22/104 1.2 (0.73
to 1.98)
0.460
Campbell et al. 1998 NP SBP and DBP target achieved 160/90 mm Hg 48 530/564 492/534 1.02
(0.99 to
1.05)
0.230
Lipids appropriately managed according to guidelines
Campbell et al. 1998 NP Patients with appropriate secondary prevention, lipids management
according to general practices: achieved target of ≤5.2 mmol/l in the
last measurement for cholesterol (recorded within three years) or if
lipids treated, checked within three months, or patient attending a
specialist clinic
12 244/593 125/580 1.91
(1.59 to
2.29)
<0.00001
Campbell et al. 1998 NP Patients with appropriate secondary prevention, lipids management
according to general practices: achieved target of ≤5.2 mmol/l in the
last measurement for cholesterol (recorded within three years) or if
lipids treated, checked within three months, or patient attending a
specialist clinic
48 325/564 284/534 1.08
(0.97 to
1.21)
0.140
Houweling et al. 2011 NP Patients achieving individual target value according to guidelines:
taking age and cardiovascular risk factors into account
14 81/102 88/104 0.94
(0.83 to
1.07)
0.330
Hemoglobin appropriately managed according to guidelines
Houweling et al. 2011 NP Haemoglobin management for the treatment of DM2 target HbA1c
<7.0
14 35/102 45/104 0.79
(0.56 to
1.12)
0.190
Houweling et al. 2011 NP Haemoglobin management for the treatment of DM2: target value for
HbA1c ≤8.5
14 88/102 91/104 0.99
(0.89 to
1.1)
0.790
Feet at risk
Houweling et al. 2011 NP Feet not at risk: examination in whom measures were taken to prevent
the development of diabetic foot symptoms
14 26/60 36/49 0.59
(0.42 to
0.82)
0.002
Asthma
Hesselink et al. 2004 LN Correct inhalation technique according to 10–item validated checklist:
less than two negative scores
12 63/95 37/74 1.33
(1.01 to
1.74)
0.040
Hesselink et al. 2004 LN Correct inhalation technique according to 10–item validated checklist:
less than two negative scores
24 58/77 36/61 1.28 (1 to
1.63)
0.050
BMI and waist circumference
Andryukhin et al. 2010 NP / LN Waist circumference: positive decrease or regression 6 27/40 10/35 2.36
(1.34 to
4.16)
0.003
Andryukhin et al. 2010 NP / LN Body mass index: decrease/regression to less than upper limit of 95%
CI or stay within 30 kg/m²
6 31/40 18/35 1.51
(1.05 to
2.17)
0.030
Adherence to treatment and diet and correct medication taken
Flynn et al. 1974 RN Correct medication taken as an indicator of health status as perceived
by the patient
6–12 32/38 12/19 1.33
(0.92 to
1.93)
0.130
Flynn et al. 1974 RN Adherence to special diet as part of a nutritional diet as indicator of
health status as perceived by the patient
6–12 8/38 6/19 0.67
(0.27 to
1.65)
0.380
Flynn et al. 1974 RN Adherence to bread as part of a nutritional diet as indicator of health
status as perceived by the patient
6–12 26/38 16/19 0.81
(0.61 to
1.09)
0.160
Flynn et al. 1974 RN Adherence to milk as part of a nutritional diet as indicator of health
status as perceived by the patient
6–12 16/38 13/19 0.62
(0.38 to
1)
0.050
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Hesselink et al. 2004 LN Improved adherence to treatment in patients under anti-inflammatory
agents
12 38/63 22/44 1.21
(0.84 to
1.72)
0.300
Hesselink et al. 2004 LN Improved adherence to treatment in patients under anti-inflammatory
agents
24 30/58 17/40 1.22
(0.79 to
1.89)
0.380
Dierick-Van Daele et
al. 2009
NP+ Adherence of clinicians to practical guidelines 0.5 143/179 96/126 1.05
(0.93 to
1.18)
0.450
Appropriate secondary prevention
Campbell et al. 1998 NP Aspirin management as secondary prevention: taken or
contraindicated by allergy or peptic ulceration
12 466/575 373/562 1.22
(1.14 to
1.31)
<0.00001
Campbell et al. 1998 NP Aspirin management as secondary prevention: taken or
contraindicated by allergy or peptic ulceration
48 396/486 348/446 1.04
(0.98 to
1.11)
0.190
Campbell et al. 1998 NP Low fat diet as appropriate secondary prevention 12 271/480 226/465 1.16
(1.03 to
1.31)
0.020
Campbell et al. 1998 NP Low fat diet as appropriate secondary prevention 48 308/464 301/440 0.97
(0.89 to
1.06)
0.520
Campbell et al. 1998 NP Moderate physical activity as appropriate secondary prevention: with
an index of physical activity of >4
12 247/587 177/568 1.35
(1.16 to
1.58)
0.000
Campbell et al. 1998 NP Moderate physical activity as appropriate secondary prevention: with
an index of physical activity of >4
48 171/494 128/455 1.23
(1.02 to
1.49)
0.030
Campbell et al. 1998 NP Non-smoking as appropriate secondary prevention 12 483/584 481/568 0.98
(0.93 to
1.03)
0.360
Campbell et al. 1998 NP Non-smoking as appropriate secondary prevention 48 422/491 398/454 0.98
(0.93 to
1.03)
0.440
Hesselink et al. 2004 LN Smoking cessation 24 4/45 6/38 0.56
(0.17 to
1.85)
0.340
Patient information and/or knowledge
Chan et al. 2009 NP+ Provision of information on the causes of illness 6 78/78 12/40 3.26
(2.05 to
5.18)
<0.00001
Kinnersley et al. 2000 NP Provision of information on the causes of illness AC 501/619 491/682 1.12
(1.06 to
1.19)
<0.0001
Kinnersley et al. 2000 NP Provision of information on the relief of symptoms AC 548/637 467/687 1.27
(1.19 to
1.34)
<0.00001
Kinnersley et al. 2000 NP Provision of information on the duration of illness AC 404/631 388/681 1.12
(1.03 to
1.23)
0.009
Kinnersley et al. 2000 NP+ Provision of information on how to reduce the chance of recurrence AC 205/603 139/662 1.62
(1.35 to
1.95)
<0.00001
Kinnersley et al. 2000 NP+ Provision of information on what to do if problems persist AC 584/628 604/686 1.06
(1.02 to
1.09)
0.002
Shum et al. 2000 NP Provision of information about self-medication 0.5–1 193/868 119/871 1.63
(1.32 to
2)
<0.00001
Shum et al. 2000 NP Provision of information about general self-management 0.5–1 709/868 502/871 1.42
(1.33 to
1.51)
<0.00001
Chan et al. 2009 NP+ Provision of leaflets about patients' disease 6 78/78 5/40 7.41 (3.4
to 16.12)
<0.00001
Flynn et al. 1974 RN Patients' knowledge of their special exercises 6–12 20/38 3/19 3.33
(1.13 to
9.83)
0.030
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Flynn et al. 1974 RN Patients' knowledge of complications of their disease 6–12 31/38 13/19 1.19
(0.85 to
1.68)
0.310
Lewis et al. 1967 LN Patients' knowledge of their diagnosis, treatment, prescriptions, family
involvement and other aspects of care
12 NR NR NR
Studies are listed in order of increasing length of follow-up, within each category of outcomes.
NP = nurse practitioner; NP+ = nurse practitioner with higher degree/course; RN = registered nurse; LN = licensed nurse; FUP = follow-up in months; n = number of
patients with events; N = total number of patients per group; RR = relative risk; CI = confidence intervals; SBP = systolic blood pressure; DBP = diastolic blood pressure;
DM2 = diabetes mellitus type 2; HbAc =, percent of glycosylated haemoglobin; mmol/l, millimoles per litre; mm Hg = millimetres of mercury; AC = after consultation.
This is not surprising. In many countries, until recently a
person did not have to hold a Bachelor’s degree in Nursing
to be a nurse and nowadays nurses might have a masters or
PhD degree. A nurse practitioner (NP) programme in the
US for example requires a graduate degree [48]. In the UK,
nurses working in NP roles were registered nurses who had
undertaken a specific course of study to at least first de-
gree (honours) level in 2008. By 2012, any nurses educa-
tionally prepared at bachelor’s or master’s level against the
Royal College of Nursing competencies were entitled to be
referred to as Advanced NPs [38]. This title requires a mas-
ter’s degree in Wales but not necessarily in the other three
countries of the UK. Whether nurses’ educational prepar-
ation or job titles (e.g. NP) with different educational de-
grees make a difference in the observed effects evaluated in
this review cannot be concluded from the studies in ques-
tion and should be examined further.
Accounts of responsibilities and tasks also varied across
trials and were not described in sufficient detail. Due to
the insufficient description of training content, we could
not identify a common component across studies. In addi-
tion, it was generally assumed that nurses had the required
competence to substitute physicians. However, the level of
substitution (clinical autonomy) differed among trials and
nurses seemed dependent of doctors’ supervision in most
studies. This may suggest the importance of collaborative
models of care. Research has shown that team approaches
in which nurses, physicians and other clinicians work col-
laboratively, might lead to better outcomes [49]. The im-
plementation of inter-professional care management pro-
grammes should also be considered in future research.
The use of process guidelines or protocols to deliver the
interventions was reported in nearly 75% of the studies
which suggests that adherence to treatment, diet and pro-
vider guidelines can result in nurse care better or similar to
Table 5: Individual trial estimates from continuous data.
Reference details Interventions,
delivered by
Outcome reported FUP, m Nurse
group,
mean (SD)
Physician
group,
mean
(SD)
SMD (95%
CI)
p-value
Asthma
Kuethe et al. 2011 NP+ Well controlled asthma based on Asthma Control Questionnaire:
optimal and validated cut-off point of 0.75 (mean score of six items)
12 –0.22 (–0.49 to 0.05) * †0.18 (–0.09
to 0.45)
‡ 0.57
Kuethe et al. 2011 NP+ Well controlled asthma based on Asthma Control Questionnaire:
optimal and validated cut-off point of 0.75 (mean score of six items)
24 0.03 (–0.26 to 0.20) * †–0.04(–0.19
to 0.27)
‡ 0.57
Visuomotor coordination
Jarman et al. 2002 LN Best hand score, health improvement 24 –45.3(21.2),
N = 696
46(21.1),
N = 558
–4.31 (–4.52
to –4.11)
<0.00001
BMI and Waist Circumference
Voogdt-Pruis et al.
2010
NP+ Body Mass Index 12 27.2(1.17),
N = 235
27.2(1.28),
N = 281
0 (–0.21 to
0.21)
1.000
Houweling et al. 2011 NP Body Mass Index 14 30.4(5.3), N
= 102
30(4.5), N
= 104
0.4 (–0.94 to
1.74)
0.560
Patient information and/or knowledge
Dierick-Van Dale et al.
2009
NP+ Provision of information on the causes of problems or illness AC 5.13(1.17),
N = 688
5.21(1.16),
N = 612
–0.08 (–0.21
to 0.05)
0.220
Dierick-Van Dale et al.
2009
NP+ Provision of information on the relief of symptoms AC 5.33(1.04),
N = 687
5.37(1.07),
N = 614
–0.04 (–0.15
to 0.07)
0.500
Dierick-Van Dale et al.
2009
NP+ Provision of information on the duration of illness AC 5.2(1.31), N
= 683
5.28(1.41),
N = 608
–0.08 (–0.23
to 0.07)
0.290
Dierick-Van Dale et al.
2009
NP+ Provision of information on how to reduce the chance of recurrence AC 5.27(1.53),
N = 685
5.42(1.62),
N = 607
–0.15 (–0.32
to 0.02)
0.090
Dierick-Van Dale et al.
2009
NP+ Provision of information on what to do if problems persist AC 5.36(1.24),
N = 684
5.3(1.51),
N = 610
0.06 (–0.09
to 0.21)
0.440
Lewis et al. 1967 LN Patients' knowledge of their diagnosis, treatment, prescriptions,
family involvement and other aspects of care
12 NR NR NR NR
Studies are listed in order of increasing length of follow-up, within each category of outcomes.
NP = nurse practitioner; NP+ = nurse practitioner with higher degree/course; RN = registered nurse; LN = licensed nurse; FUP = follow-up in months; n = number of
patients with events; N = total number of patients per group; SD = standard deviation; SMD = standard mean difference; CI = confidence intervals; AC = after consultation.
* Mean difference (90%CIs) for Nurses vs. General Physicians
† Mean difference (90%CIs) for Nurses vs. Paediatricians
‡ Nurses/General Physicians vs. Nurses/Paediatricians
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that of physicians. In fact, the use of evidence-based clinic-
al guidelines has shown effective improvement in the pro-
cess and structure of care [50], and has been reported to
aid the transfer of tasks between clinicians while maintain-
ing and improving the quality of care [51]. The lack of re-
porting in adherence to guidelines or protocols in the oth-
er 25.6% of the studies may just be an indicator of the
level of adherence and availability of guidelines in prac-
tice. These differences may result from the time and meth-
od of development, type of health problem, content of re-
commendations, and source of dissemination within others
[52]. The finding that nurses are significantly more likely
than physicians to provide life-style advice and informa-
tion about various aspects of disease is consistent with pre-
vious reviews [9, 10], research reporting positive associ-
ations of nurse lifestyle interventions in the prevention of
chronic disease [53] and reports showing patients’ appre-
ciation to nurses’ involvement especially in education and
counselling [54].
Despite all limitations, no study showed harm of nurse-led
care interventions compared to physician-led care. Trained
nurses seem to provide equal or better care compared to
physicians for the management of chronic disease through
process of care measures, within their scope of practice. We
speculate that, regardless of the healthcare system in which
nurses substitute physicians, and given the heterogeneity
in patient populations, settings and interventions, the reas-
ons for these effects may be that specific components of
nurse training and competency are shared among studies
(e.g. patient education). Another possibility is that nurses
may adhere to process care guidelines and protocols better
than physicians. In addition, individual trial estimates sug-
gest that the effects of interventions may only be signific-
ant at short term (≤12 months), for some conditions such
as asthma and COPD. These factors may have a signific-
ant impact on the continuity and quality of patient care and
should be investigated in future studies.
Strengths and limitations of this systematic review
To our knowledge, this is the first systematic review of
physician-nurse substitution with a focus on process of care
outcomes. Our review updates earlier systematic reviews
[9, 10] and uses a comprehensive search of the literature
and critical appraisal of RCTs which are at lower risk of bi-
as than other study designs [14, 55]. A particular strength
of our review is that we examined individual trial data in
relation to nurses’ competencies and roles. It was however
often difficult to understand in detail the role and respons-
ibilities of nurses when substituting physicians. In many
cases, nurses remain embedded in care teams that also in-
volved physicians. It was also difficult to determine the
nurses’ level of education and whether the training com-
petencies were appropriate for the type of care delivered.
In many cases the description of training content is insuf-
ficient and limited the identification of common program
components across studies. We excluded studies in which
nurse-led teams were compared to physician-led care in a
primary care base because of the potential confounding in
the type of care/tasks (e.g. specialised vs. routine) and the
type of clinician delivering the interventions. A limitation
of the literature is the small number of studies that met
the inclusion criteria. Although we did not search for grey
literature and included publications in English only, we
used thorough electronic and hand searches including the
screening of relevant reviews (some in foreign languages).
We did not contact study authors to further obtain or clarify
missing information.
Conclusion
Our systematic review suggests that, in terms of process of
care outcomes, special trained nurses can provide care that
is at least as equivalent to care provided by physicians for
chronic diseases such as diabetes, cardiovascular disorders,
asthma, COPD, and hypertension. One limiting factor is the
small number of studies reporting many unique processes
of care measures. It is unclear whether the observed ef-
fects are due to the diversity in nurses’ competencies, roles,
and experiences. It is also unclear whether the components
or contents of training competencies boost these effects.
Future studies could benefit from the inclusion of larger
samples, a more rigorous methodology, longer follow-up
episodes, and mapping the wider range of nurse care from
many countries. Consideration should be given to the role
of multidisciplinary teams in which nurses embed their
roles. Qualitative research could also add valuable inform-
ation since it may allow the identification of factors that
influence the performance and quality of care within the
context of health care systems [56]. Future studies should
especially provide precise accounts of the components of
competencies or training programmes, and the qualifica-
tions, tasks and responsibilities of clinicians delivering sub-
stitution of care. In particular, the reporting of complex in-
terventions according to recently proposed guidelines [57]
may help establishing better reporting of substitution of
care studies in the future. Consequently improving the in-
terpretation of results and allowing the replication of inter-
ventions, so that future evaluations in decision-making can
employ such evidence.
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Annex: Supplementary data.
Table S1: PRISMA Checklist.
Table S2: Search strategy in Ovid Medline.
Similar search strategies were performed and run in EMBASE, The Cochrane Library of Systematic Reviews and CINAHL and include specific
search filters for RCTs.
Table S3: Studies excluded with reasons for exclusion based on appraisal of full text articles.
Table S4: Characteristics of participants, interventions and outcomes in the studies included in review.
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Table S1: PRISMA Checklist. From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097
Section/topic # Checklist item Reported
on page
#
TITLE
Title 1 Identify the report as a systematic review, meta-analysis, or both. 1
ABSTRACT
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria,
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and
implications of key findings; systematic review registration number.
1
INTRODUCTION
Rationale 3 Describe the rationale for the review in the context of what is already known. 1
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions,
comparisons, outcomes, and study design (PICOS).
2
METHODS
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide
registration information including registration number.
2
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered,
language, publication status) used as criteria for eligibility, giving rationale.
2
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify
additional studies) in the search and date last searched.
2
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be
repeated.
2 and
Table S2
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable,
included in the meta-analysis).
2
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes
for obtaining and confirming data from investigators.
2
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and
simplifications made.
2
Risk of bias in individual studies 12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was
done at the study or outcome level), and how this information is to be used in any data synthesis.
2, 3
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). 2, 3
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency
(e.g., I2) for each meta-analysis.
2, 3
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective
reporting within studies).
2, 3
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating
which were pre-specified.
NA
RESULTS
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at
each stage, ideally with a flow diagram.
3,
figure 1
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and
provide the citations.
3,
table 1,
table 2,
table S4
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). 4,
table 3
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
4–7,
table 4,
table 5
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency. NA
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15). 4,
Table 3
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]). NA
DISCUSSION
Summary of evidence 24 Summarise the main findings including the strength of evidence for each main outcome; consider their relevance to
key groups (e.g., healthcare providers, users, and policy makers).
7–11
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of
identified research, reporting bias).
11
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research. 11
FUNDING
Funding 27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the
systematic review.
11
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Table S2: Search strategy in Ovid Medline*
Item,
#
Searches Results
1 exp General Practice/ or exp Primary Health Care/ or exp Private Practice/ or Family Physicians/ or general practitioners/ or physicians, primary
care/ or exp geriatrics/ or Geriatric Assessment/ or exp pediatrics/
235,871
2 exp Nursing Care/ or Primary Nursing/ or Community Health Nursing/ or Family Nursing/ or Nursing, Practical/ or Advanced Practice Nursing/ or
exp Geriatric Nursing/ or exp Pediatric Nursing/
132,684
3 exp Ambulatory Care/ or ambulatory care facilities/ or community health centers/ or maternal-child health centers/ or outpatient clinics, hospital/
or pain clinics/ or surgicenters/
78,635
4 (primary adj2 (health?care$ or care$ or medic$)).ti,ab,hw. 106,920
5 ((family adj2 (physician$ or doctor or practitioner or practice or internist or medic$)) or (general adj2 (internist or physician$ or doctor or
practitioner or practice or medic$ or care$ or health$care$)) or (personal adj2 (doctor or physician$)) or (physician$ adj2 (practitioner or
practice)) or (internal adj medicine) or geriatri$ or paediatri$ or pediatri$).ti,ab,hw,mp.
500,300
6 ((community or ambulatory or shared) adj4 (care$ or health$care) adj4 (facility or facilities or service$ or cent$ or clinic$)).ti,ab,hw. 16,580
7 or/1-6 769,622
8 exp Physician Assistants/ or nurse clinicians/ or nurse practitioners/ 24,593
9 (nurs$ adj2 (family or primary or care$ or practitioner or practice or clinic$ or regist$ or specialist$ or leader or consultant$ or physician$ or
expert or district or advanced or assessment or visit$ or geriatri$ or paediatri$ or pediatri$)).tw,mp.
158,263
10 ((nurs$ adj2 appropriately adj trained) or (nurs$ adj2 community adj2 health adj2 care) or (nurs$ adj2 first contact) or (assistan$ adj2 (physician$
or medic$ or health$care$)) or (clinic$ adj2 support) or (clinic$ adj2 (nurse$led or nurse led))).ti,ab,hw.
22,441
11 or/8-10 185,383
12 Nurse's Practice Patterns/ 859
13 delegation, professional/ 397
14 professional autonomy/ 8,318
15 Clinical Competence/ 63,230
16 exp Professional Role/ 64,848
17 12 or 13 or 14 or 15 or 16 128,,584
18 (((substitut$ or transfer$ or swap or replac$) adj3 (((doctor$ or GP or GPs or physician$ or practi$ or general) adj2 practitioner$) or job or role or
task$ or skill$ or perform$ or responsibility or autonom$)) or ((delegat$ or supervis$) adj5 (responsibility or performance$ or role$ or job or
tasks)) or (autonom$ adj (professional or responsibility or self$regulation)) or (clinical adj skill$ adj competence) or (((skill$mix or skill$) adj mix$)
or skill$) or (role$ adj4 (advance or chang$ or enhanc$ or expan$ or transfer$)) or (team$ adj4 (patient care or multidisciplinary or cooperation)
adj4 autonom$)).ti,ab,hw.
166,854
19 17 or 18 277,555
20 7 and 11 and 19 15,643
21 (letter or letter$).pt,sh. or (editorial or historical article or anecdote or commentary or note or case report$ or case study).pt. or (editorial or
historical article or anecdote or commentary or note or case report$ or case study).pt. or (animal studies or animals, laboratory or experimental
animal or animal experiment or animal model or rodentia or rodents or rodent).sh.
2,968,746
22 (randomi?ed controlled trial or controlled clinical trial).pt. or (randomi?ed or placebo or randomly or trial or groups).ab. 1,926,021
23 exp cluster analysis/ or cross-over studies/ or ((cluster$ adj2 random$) or (communit$ adj2 intervention$) or (communit$ adj2 random$)).mp. 83,918
24 ((non$equivalent adj3 control$) or posttest$ or post test$ or post-test$ or pre test$ or pretest$ or pre-test$ or quasi-experiment$ or quasi
experiment$ or quasiexperiment$ or timeseries or time series or time-series or (time adj2series adj2 analysis) or (interrupted adj2 time
adj2series)).mp.
40,132
25 22 or 23 or 24 1,993,858
26 25 not 21 1,965,071
27 20 and 26 1,511
28 limit 27 to humans (updated by mid-February 2014) 1,459
* Similar search strategies were performed and run in EMBASE, The Cochrane Library of Systematic Reviews and CINHAL and include specific search
filters for RCTs.
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Table S3: Studies excluded with reasons for exclusion based on appraisal of full text articles.
Ref. # Reference to study Reason for exclusion
1 Dierick-Van Daele ATM, Steuten LMG, Metsemakers JFM, Derckx EWCC, Spreeuwenberg C, Vrijhoef HJM.
Economic evaluation of nurse practitioners versus GPs in treating common conditions. British Journal of
General Practice. 2010;60:28-33.
Outcomes of interest not reported.
2 Du Moulin MFMT, Hamers JPH, Paulus A, Berendsen CL, Halfens R. Effects of introducing a specialized
nurse in the care of community-dwelling women suffering from urinary incontinence: a randomized controlled
trial. J Wound Ostomy Continence Nurs. 2007;34:631-40.
Outcomes of interest not reported.
3 Fairall L, Bachmann MO, Lombard C, Timmerman V, Uebel K, Zwarenstein M, et al. Task shifting of
antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel,
cluster-randomised trial. The Lancet. 2012.
Outcomes of interest not reported.
4 Hemani A, Rastegar DA, Hill C, al-Ibrahim MS. A comparison of resource utilization in nurse practitioners and
physicians. Eff Clin Pract. 1999;2:258-65.
Outcomes of interest not reported.
5 Hiss RG, Armbruster BA, Gillard ML, McClure LA. Nurse care manager collaboration with community-based
physicians providing diabetes care: a randomized controlled trial. Diabetes Educator. 2007;33:493-502.
Outcomes of interest not reported.
6 Hollinghurst S, Horrocks S, Anderson E, Salisbury C. Comparing the cost of nurse practitioners and GPs in
primary care: modelling economic data from randomised trials. British Journal of General Practice.
2006;56:530-5.
Outcomes of interest not reported.
7 Kernick D, Cox A, Powell R, Reinhold D, Sawkins J, Warin A. A cost consequence study of the impact of a
dermatology-trained practice nurse on the quality of life of primary care patients with eczema and psoriasis.
British Journal of General Practice. 2000;50:555-8.
Outcomes of interest not reported.
8 Kernick D, Powell R, Reinhold D. A pragmatic randomised controlled trial of an asthma nurse in general
practice. Primary Care Respiratory Journal. 2002;11:6-8.
Outcomes of interest not reported.
9 Lenz ER, Mundinger MO, Kane RL, Hopkins SC, Lin SX. Primary care outcomes in patients treated by nurse
practitioners or physicians: two-year follow-up. Med Care Res Rev. 2004;61:332-51.
Outcomes of interest not reported.
10 Mundinger MO, Kane RL, Lenz ER, Totten AM, Tsai WY, Cleary PD, et al. Primary care outcomes in patients
treated by nurse practitioners or physicians: a randomized trial. Jama. 2000;283:59-68.
Outcomes of interest not reported.
11 Venning P, Durie A, Roland M, Roberts C, Leese B. Randomised controlled trial comparing cost effectiveness
of general practitioners and nurse practitioners in primary care. BMJ. 2000;320:1048-53.
Outcomes of interest not reported.
12 Winter C. Quality health care: patient assessment [MSc]. Long Beach, CA: California State University; 1981. Outcomes of interest not reported.
13 Blanchard MR, Waterreus A, Mann AH. The effect of primary care nurse intervention upon older people
screened as depressed. Int J Geriatr Psychiatry. 1995;10:289-98.
Cohort study and multidisciplinary team approach.
14 Blanchard MR, Waterreus A, Mann AH. Can a brief intervention have a longer-term benefit? The case of the
research nurse and depressed older people in the community. Int J Geriatr Psychiatry. 1999;14:733-8.
Nurse working in close collaboration with other
clinicians.
15 Cave AJ, Wright A, Dorrett J, McErlain M. Evaluation of a nurse-run asthma clinic in general practice. Primary
Care Respiratory Journal. 2001;10:65-8.
Not an intervention comparison between nurses
and physicians.
16 Krein SL, Klamerus ML, Vijan S, Lee JL, Fitzgerald JT, Pawlow A, et al. Case management for patients with
poorly controlled diabetes: a randomized trial. Am J Med. 2004;116:732-9.
Nurse working in close collaboration with other
clinicians based on a chronic care model.
17 Lapointe F, Lepage S, Larrivee L, Maheux P. Surveillance and treatment of dyslipidemia in the post-infarct
patient: can a nurse-led management approach make a difference? Can J Cardiol. 2006;22:761-7.
Intervention (telephone) not of interest for this
review and not part of usual care interventions of
physicians.
18 Leenders F, Beusmans G, Swerts H, editors. A practice nurse for patients with cardiovascular disease, an
explorative study 2006.
Report in Dutch. Version of article in English was
not found.
19 Lewis CE, Resnik BA, Schmidt G, Waxman D. Activities, events and outcomes in ambulatory patient care. N
Engl J Med. 1969;280:645-9.
Not at RCT.
20 Sackett DL, Spitzer WO, Gent M, Roberts RS. The Burlington randomized trial of the nurse practitioner: health
outcomes of patients. Ann Intern Med. 1974;80:137-42.
No real substitution. At least 30% of patients in
both groups were seen by the physicians at the
end of study and data not split into mutually
exclusive groups.
21 Spitzer WO, Sackett DL, Sibley JC, Roberts RS, Gent M, Kergin DJ, et al. The Burlington randomized trial of
the nurse practitioner. N Engl J Med. 1974;290:251-6.
No real substitution. At least 30% of patients in
both groups were seen by the physicians at the
end of study and data not split into mutually
exclusive groups.
22 Tonstad S, Alm CS, Sandvik E. Effect of nurse counselling on metabolic risk factors in patients with mild
hypertension: a randomised controlled trial. Eur J Cardiovasc Nurs. 2007;6:160-4.
No real substitution. In both experimental and
control groups the nurse provides interventions at
different stages of care.
23 Van Son L, Vrijhoef, H. Supporting the general practitioner. A randomized controlled trial investigation the
effects of a practice nurse on asthma, COPD, and diabetes. 2004; Huisarts en wetenschap:15-21.
Report in Dutch. Version of article in English was
not found.
24 Williams KS, Assassa RP, Cooper NJ, Turner DA, Shaw C, Abrams KR, et al. Clinical and cost-effectiveness
of a new nurse-led continence service: a randomised controlled trial. Br J Gen Pract. 2005;55:696-703.
Nurse working in close collaboration with other
clinicians. Control group received care from
nurses, physicians and specialists and data not
split into mutually exclusive groups.
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Table S4: Characteristics of participants, interventions and outcomes, in the studies included in review.
Study Participants Intervention Outcomes
First
author,
year
Location Design,
period*
Included Excluded Care delivered Clinical autonomy Follow-
up,
months
Reported
Houweling
et al. 2011
NL 5 RCT, period
NR.
Patients under treatment
and under medication for
diabetes mellitus type 2,
with HbA1c
measurements within the
last three years.
Patients with diabetes
mellitus type 2 not being
treated in primary care
setting, inability to
participate because of
age, comorbidities or -in
the opinion of the
general practitioner-
whoever was not willing
to return for follow-up.
Practice nurse with one
week training in diabetes
mellitus to manage
transferred patients
based on guidelines.
Full responsibility. 14 BP, TC, GH,
TC/HDL ratio.
Kuethe et
al. 2011
NL 4 RCT,
2006–2008.
Patients 6‒16 years old
with moderate and
stable asthma, in
treatment of inhalative
corticosteroids at least
nine months before the
start of the study,
informed consent.
Patients not able to
perform lung function
tests, or who had other
chronic diseases.
Asthma nurse to
manage patients based
on guidelines.
Nurses needed support
from/or short
communication with
paediatrician.
24 Lung
function:
PD20,
%FEV1,
FENO.
Voogdt-
Pruis et al.
2010
NL 3 RCT,
2006–2007.
Patients 30‒74 years of
age, with cardiovascular
disease or hypertension
and/or
hypercholesterolemia,
with at least 10% in
10-year risk of
cardiovascular disease;
risk due to systolic blood
pressure of ≥140 or total
cholesterol of ≥6.5
mmol/l within the
previous six months.
Patients visiting
specialist in
cardiovascular disease
more than once per year,
diabetes mellitus, severe
comorbidities.
Nurse-led care based on
Dutch guidelines for
cardiovascular risk
management. Advance
practice nurse managed
cardiovascular risk
including primary and
secondary prevention.
NR. 12 BP, TC.
Andryukhin
et al. 2010
RU 1 RCT,
2006–2009.
Patients of at least 50
years of age with Heart
Failure with preserved
ejection fraction,
informed consent.
Patients with blood
pressure of <90/60 mm
Hg or >160/100 mm Hg,
under optimal
antihypertensive therapy,
acute coronary
syndrome within
previous six months,
significant valvular
stenosis, insulin diabetes
mellitus dependent,
confirmed chronic
obstructive pulmonary
disease, conditions
limiting participation in
the rehabilitation (see
reference for more
details).
Nurse-led care based on
Russian National
guidelines. Nurses with
special degree in patient
education obtained in
joint course: patient
education, treatment and
exercise training
information and
counselling.
Prescription of
medication and non-
pharmacological
measures (diet, alcohol
intake, weight reduction,
smoking cessation,
activity and exercise
training) provided by
physician.
6 TC, GH, LDL,
cardiac
function and
inflammation.
Dierick-
Van Daele
et al. 2009
NL 2 RCT, 2006. Patients with common
complaints aged ≥16
who sought physician for
initial consultation
Patients unregistered in
practice, language or
reading problems, or
with reason for
appointment not
provided.
Nurse practitioner with
Master degree in AN,
trained in common
complaints to manage
patients based on GDLs
(assess symptoms,
perform PE and
diagnosis; decisions on
further treatment,
prescribing, referrals to
1ry and 2ry services,
ordering clinical tests
and investigations)
Prescriptions and
referrals had to be
validated by physician.
0.5, AC Adherence to
practical
guidelines,
provision of
information
about causes
and duration
of disease,
symptoms
relief,
recurrences
minimisation
and how to
deal with
persistent
issues.
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Chan et al.
2009
UK 6 RCT,
2002–2004.
Patients with mild
gastro-oesophageal
reflux disease or
moderate gastritis
referred to gastroscopy
for evaluation
Patients with sinister
symptoms (dysphagia,
vomiting, anaemia, rapid
weight loss, history of
gastric surgery, severe
gastroscopic findings
e.g. peptic ulcer, tumour,
esophagitis grade C/D,
Barrett's oesophagus
Gastrointestinal nurse
practitioner to manage
Dyspepsia based on
GDLs and to run follow
to up clinic for
consultations following
gastroscopy.
Authorised to adopt
treatment according to
GDLs and perform
specific tests (e.g. breath
urea, barium meal).
6 Provision of
information
on cause of
illness and
provision of
leaflets about
the disease.
Hesselink
et al. 2004
NL 1 RCT,
1998–2002.
Patients with asthma,
COPD or mixed disease
aged 16 to 75 years,
with symptoms (cough,
phlegm or dyspnoea)
within year before study,
with current use of
COPD or asthma
medication
Patients with presence
of other pulmonic
disease, terminal
disease
Physician's assistants to
manage patients based
on semi-structured
protocols: Asthma and
COPD patient education
No (details NR). 24, 12 Correct
inhalation
technique,
treatment
adherence
and smoking
cessation.
Denver et
al. 2003
UK 5 RCT,
2000–2001.
Patients with diabetes
mellitus type 2, previous
diagnosis of
hypertension, or who
were in receipt of blood
pressure lowering
treatment.
Patients with life-
threatening
comorbidities requiring
intensive management.
Hypertension nurse care
based on clinical
guidelines.
No (details NR). 6 BP, TC, HG,
HDL,
triglycerides,
kidney
function.
Jarman et
al. 2002
UK 4 RCT,
1996–1999.
Patients with Parkinson's
disease taking one or
more anti-Parkinson
drugs, informed consent.
Patients younger than17
years of age, severe
mental illness, sufficient
cognitive impairment.
Community nurse with a
course in Parkinson's
disease: advised
physicians, provided
patient counselling and
education, treatment
information and
monitoring; reporting to
physicians, instigating
respite, day hospital care
and discharge;
assessment of patient
social security, liaison
with multidisciplinary
primary care teams for
ongoing assessment and
therapy.
Nurses were under
guidance of a nurse
manager but had
advisory position to
physicians with whom
patients' records were
discussed.
24 Stand-up and
mobility
(tests).
Kinnersley
et al. 2000
UK 3 RCT, period
NR.
Patients with diverse
complaints requesting
same day appointments,
informed consent
Patients seemingly too ill
to wait or unable to
understand the research,
women seeking
emergency
contraception
Nurse practitioner with a
nurse diploma on care
for same day
consultations for primary
care
Physicians were always
available to prescribe
when necessary.
AC Provision of
information
about causes
and duration
of disease,
symptoms
relief,
recurrences
minimisation
and how to
deal with
persistent
issues.
Shum et
al. 2000
UK 2 RCT,
1998–1999.
Patients with minor
illnesses aged ≥1 years,
who requested and were
given appointment on
the same day, informed
consent
Patients with pregnancy
problems, severe chest
or abdominal pain,
severe breathing
problems, vomiting
blood, fits or blackouts,
psychiatric problems,
literacy or language
difficulties
Nurse practitioner who
had no specific
experience in seeing
patients with minor
illnesses but took a
course on managing
minor illnesses and were
piloted before the study:
management, history
taking, physical
examinations, advice
and treatment,
prescribing and referral
Prescriptions required a
doctor's signature.
0.5–1 Provision of
information
about self-
medication
and general
self-
management.
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Campbell
et al. 1998
UK 1 RCT,
1995–1996.
Patients with CHD Patients with terminal
illness, dementia,
housebound patient,
explicit request to see
physician.
Health visitors, district
and practice nurses with
training in clinic
protocols/GDLs and
techniques to facilitate
behavioural change:
secondary prevention of
CHD.
No full responsibility to
manage patients.
12, 48 BP and lipids
managed
according to
GDLs,
appropriate
secondary
prevention
through
aspirin
management,
low-fat diet,
physical
activity and
non-smoking.
Flynn et al.
1974
US 2 RCT, 1971. Patients with
undifferentiated
conditions with informed
consent were referred to
nurse clinician
NR Nurse clinicians with
training in service
delivery including health
status, quantity and
efficiency of care.
Nurses were authorised
to order medication and
tests.
6–12 Adherence to
treatment
and diet and
patients'
knowledge of
their
complications
of disease
and on their
exercises
prescribed.
Lewis et al.
1967
US 1 RCT, period
NR.
Patients with HBP, CVD,
obesity, somatisation
problems, rheumatoid or
degenerative arthritis
NR Nurses who provided
primary source care for
at least 1 year before the
study to provide care
based on GDLs: routine
management, schedule
appointments and care
following standing orders
written for patients in
each diagnostic class.
The diagnostic class
defined the limits for
nurses autonomy i.e.
initiation or alteration of
care; patient charts seen
by nurse were reviewed
daily by 1‒2 physicians
involved in the project.
12 Patients'
knowledge of
their
diagnosis,
treatment,
prescriptions,
family
involvement
or other
aspects of
care.
Studies are listed by year (y) of publication, in decreasing order.
US = United States; NL = The Netherlands; UK = United Kingdom; ZA = South Africa; RU = Russia; RCT = randomised controlled trial; cRCT = cluster randomised
controlled trial; NR = not reported; ART = antiretroviral therapy; HbA1c = haemoglobin; BP = blood pressure; TC = total cholesterol; GH = glycosylated haemoglobin; CD4
= T-cell surface glycoprotein CD4; HDL = high density lipoprotein levels; LDL = low density lipoprotein; PD20 = provocative dose of methacholine causing a 20% fall in
forced expiratory volume in one second (FEV1); FENO = fraction of exhaled nitric oxide; AC = after consultation.
* start and end year when studies were conducted.
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Figures (large format)
Figure 1
Flow diagram – study selection process.
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